Search Results Search Sort by RelevanceMost Recent Case and Commentary Nov 2012 Surgery for Placebo Effect? Commentary 2 Matthew J. Matava, MD and Charles Carroll IV, MD If a physician worries that a treatment will benefit the patient through the placebo effect, should he perform it? Virtual Mentor. 2012;14(11):828-834. doi: 10.1001/virtualmentor.2012.14.11.ecas1-1211. Case and Commentary Jan 2005 Mrs. Douglas's Choice of Treatment for Her Husband, Option Assessment Jennifer Reenan, MD Virtual Mentor. 2005;7(1):35-42. doi: 10.1001/virtualmentor.2005.7.1.ccas7a-0501. Case and Commentary Jan 2005 Mrs. Douglas's Choice of Treatment for Her, Option Comparison Jennifer Reenan, MD Virtual Mentor. 2005;-. doi: 10.1001/virtualmentor.2005.7.1.ccas7b-0501. Case and Commentary Jan 2005 Mrs. Douglas's Choice of Treatment for Her Husband, Additional Information Jennifer Reenan, MD Virtual Mentor. 2005;7(1):35-42. doi: 10.1001/virtualmentor.2005.7.1.ccas7c-0501. Case and Commentary Nov 2019 How Should Surgeons Balance Transplantation Innovation With Acceptance of a Trauma Survivor’s Appearance? Carly Parnitzke Smith, PhD Counseling a patient about reconstructive surgery for a traumatic and disfiguring injury requires special consideration. AMA J Ethics. 2019;21(11):E953-959. doi: 10.1001/amajethics.2019.953. Case and Commentary May 2024 Should Antimicrobial Resistance Limit Access to an Organ Transplant? Andrew Courtwright, MD, PhD This article discusses fiduciary obligations transplant programs might have to patients with B cenocepacia. AMA J Ethics. 2024;26(5):E367-372. doi: 10.1001/amajethics.2024.367. Case and Commentary Nov 2004 Clinical Trials and End-of-Life Decision Making, Commentary 2 Lucy Godley, MD, PhD Physicians can help oncology patients decide whether to focus on aggressive chemotherapy or less aggressive comfort measures for end-of-life care. Virtual Mentor. 2004;6(11):479-481. doi: 10.1001/virtualmentor.2004.6.11.ccas1-0411. Case and Commentary Nov 2004 Clinical Trials and End-of-Life Decision Making, Commentary 1 David S. Alberts, MD Physicians can help oncology patients decide whether to focus on aggressive chemotherapy or less aggressive comfort measures for end-of-life care. Virtual Mentor. 2004;6(11):477-479. doi: 10.1001/virtualmentor.2004.6.11.ccas1-0411. Pagination First page « First Previous page ‹ Previous Page 1 Current page 2
Case and Commentary Nov 2012 Surgery for Placebo Effect? Commentary 2 Matthew J. Matava, MD and Charles Carroll IV, MD If a physician worries that a treatment will benefit the patient through the placebo effect, should he perform it? Virtual Mentor. 2012;14(11):828-834. doi: 10.1001/virtualmentor.2012.14.11.ecas1-1211.
Case and Commentary Jan 2005 Mrs. Douglas's Choice of Treatment for Her Husband, Option Assessment Jennifer Reenan, MD Virtual Mentor. 2005;7(1):35-42. doi: 10.1001/virtualmentor.2005.7.1.ccas7a-0501.
Case and Commentary Jan 2005 Mrs. Douglas's Choice of Treatment for Her, Option Comparison Jennifer Reenan, MD Virtual Mentor. 2005;-. doi: 10.1001/virtualmentor.2005.7.1.ccas7b-0501.
Case and Commentary Jan 2005 Mrs. Douglas's Choice of Treatment for Her Husband, Additional Information Jennifer Reenan, MD Virtual Mentor. 2005;7(1):35-42. doi: 10.1001/virtualmentor.2005.7.1.ccas7c-0501.
Case and Commentary Nov 2019 How Should Surgeons Balance Transplantation Innovation With Acceptance of a Trauma Survivor’s Appearance? Carly Parnitzke Smith, PhD Counseling a patient about reconstructive surgery for a traumatic and disfiguring injury requires special consideration. AMA J Ethics. 2019;21(11):E953-959. doi: 10.1001/amajethics.2019.953.
Case and Commentary May 2024 Should Antimicrobial Resistance Limit Access to an Organ Transplant? Andrew Courtwright, MD, PhD This article discusses fiduciary obligations transplant programs might have to patients with B cenocepacia. AMA J Ethics. 2024;26(5):E367-372. doi: 10.1001/amajethics.2024.367.
Case and Commentary Nov 2004 Clinical Trials and End-of-Life Decision Making, Commentary 2 Lucy Godley, MD, PhD Physicians can help oncology patients decide whether to focus on aggressive chemotherapy or less aggressive comfort measures for end-of-life care. Virtual Mentor. 2004;6(11):479-481. doi: 10.1001/virtualmentor.2004.6.11.ccas1-0411.
Case and Commentary Nov 2004 Clinical Trials and End-of-Life Decision Making, Commentary 1 David S. Alberts, MD Physicians can help oncology patients decide whether to focus on aggressive chemotherapy or less aggressive comfort measures for end-of-life care. Virtual Mentor. 2004;6(11):477-479. doi: 10.1001/virtualmentor.2004.6.11.ccas1-0411.